# Dose- and Time-Dependent Effects of Cobalt Chloride Supplementation on Growth Performance and Intestinal Development in Weaned Piglets

**Authors:** Min Wang, Siqi Li, Xin Wang, Yutong Zeng, Mingming Guo, Zhaobin Wang, Lanmei Yin, Qiye Wang, Jianzhong Li, Huansheng Yang

PMC · DOI: 10.3390/ani16030440 · Animals : an Open Access Journal from MDPI · 2026-01-30

## TL;DR

This study shows that low-dose cobalt chloride helps weaned piglets grow better and reduces diarrhea in the short term, but higher doses or longer use can harm intestinal health and growth.

## Contribution

The study reveals dose- and time-dependent effects of cobalt chloride on piglet growth and intestinal development, highlighting optimal short-term use.

## Key findings

- Low-dose cobalt chloride improves early post-weaning growth and reduces diarrhea.
- High-dose or prolonged cobalt chloride use reduces feed intake and alters intestinal morphology and gene expression.
- Cobalt chloride affects nutrient transport and metabolism-related genes in a dose-dependent manner.

## Abstract

Weaning is a critical period for piglets and is commonly associated with diarrhea, impaired intestinal function, and reduced growth performance. This study investigated the effects of dietary cobalt chloride supplementation on growth, diarrhea incidence, and intestinal development in weaned piglets. Piglets were fed diets containing no cobalt chloride, a low level, or a higher level for four weeks after weaning. During the first two weeks post-weaning, cobalt chloride supplementation was associated with favorable trends in growth performance and reduced diarrhea. In contrast, continuous supplementation for four weeks, particularly at the higher dietary level, was associated with reduced feed intake, slower growth, and unfavorable changes in intestinal development. These changes included alterations in intestinal morphology, epithelial cell differentiation, and the expression of genes involved in nutrient transport and energy metabolism. Overall, the results suggest that low-level cobalt chloride supplementation may be beneficial during the early post-weaning period, whereas prolonged supplementation or higher dietary inclusion levels should be applied with caution.

The aim of our study was to evaluate the effect of dietary cobalt chloride (CoCl2) supplementation on diarrhea, growth performance, and intestinal development in post-weaning piglets. Twenty-six piglets weaned at 21 days of age (d 21) with similar body weights were randomly assigned to three treatments: a control group (n = 10), a low-dose CoCl2 group (1 mg/kg of diet; n = 8) and a high dose CoCl2 group (2 mg/kg of diet, n = 8). Piglets were housed individually and fed the experimental diets for 28 days, with a dietary transition at day 15. During the early post-weaning period (d0 to d14), dietary CoCl2 supplementation was associated with favorable trends in growth performance parameters, including ADG (average daily gain: linear, 0.05 < p < 0.1) and gain to feed ratio (linear, p < 0.05), as well as reduced fecal scores (Linear, p < 0.05). However, during the later post-weaning period (d15 to d28), increasing dietary CoCl2 levels were unfavorable trends in feed intake (Linear, p < 0.05) and ADG (Linear, 0.05 < p < 0.1). At the intestinal level, CoCl2 supplementation was associated with dose-related changes in intestinal morphology, epithelial cell differentiation, and luminal pH. Alterations were observed in duodenal crypt depth (CD) and ileal villus height (VH), and duodenal VH/CD (Linear, p < 0.05), without significant effects on ileal epithelial proliferation and apoptosis (p > 0.1). Changes in the numbers of goblet cells in villi (Quadratic, p < 0.05) and crypt (Linear, p < 0.05), and enteroendocrine cells (Quadratic, p < 0.05) in crypt exhibited dose-dependent trends. In addition, with the increase in the CoCl2 concentration, the expressions of genes related to nutrient transporters (DMT1, GLUT2, and SGLT1) and metabolism (HIF-1α, FBP1, and FBP2), as well as those related to the NOTCH signaling pathway (LGR5, ATOH1, HES1, and NOTCH2), showed a linear decrease (Liner, p < 0.05). This was the case except for LDHA and DLL4 (Liner, p < 0.05). The expression of the former was the lowest in the high-dose group, while that of the latter was the lowest in the low-dose group. In vitro, CoCl2 exposure was associated with reduced organoid budding rates (Quadratic, p < 0.01), the budding numbers (Linear, p < 0.05) per organoid, and altered gene expression of SGLT1 and CHGA (Linear, p < 0.05). In summary, dietary supplementation with CoCl2 exhibited dose- and time-dependent trends in weaned piglets. CoCl2 supplementation during the early post-weaning period (two weeks after weaning) was associated with favorable trends in growth performance and diarrhea, whereas prolonged supplementation (4 weeks after weaning) or higher dietary level (2 mg/kg of diet) were associated with unfavorable trends in growth performance and intestinal development. These findings suggest that CoCl2 may have potential as a short-term (two weeks after weaning), low-level (below 2 mg/kg diet) nutritional supplement, while caution is warranted regarding long-term supplementation or higher dietary inclusion levels.

## Linked entities

- **Genes:** DMRT1 (doublesex and mab-3 related transcription factor 1) [NCBI Gene 1761], SLC2A2 (solute carrier family 2 member 2) [NCBI Gene 6514], SLC5A1 (solute carrier family 5 member 1) [NCBI Gene 6523], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], FBP1 (fructose-bisphosphatase 1) [NCBI Gene 2203], FBP2 (fructose-bisphosphatase 2) [NCBI Gene 8789], LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549], ATOH1 (atonal bHLH transcription factor 1) [NCBI Gene 474], HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280], NOTCH2 (notch receptor 2) [NCBI Gene 4853], LDHA (lactate dehydrogenase A) [NCBI Gene 3939], DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567], CHGA (chromogranin A) [NCBI Gene 1113]
- **Chemicals:** cobalt chloride (PubChem CID 24288), CoCl2 (PubChem CID 6371)
- **Diseases:** diarrhea (MONDO:0001673)

## Full-text entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567] {aka AOS6, delta4, hdelta2}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, LDHA (lactate dehydrogenase A) [NCBI Gene 3939] {aka GSD11, HEL-S-133P, LDHM, PIG19}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, ATOH1 (atonal bHLH transcription factor 1) [NCBI Gene 474] {aka ATH1, DFNA89, HATH1, MATH-1, bHLHa14}, SLC2A2 (solute carrier family 2 member 2) [NCBI Gene 6514] {aka GLUT2}, FBP2 (fructose-bisphosphatase 2) [NCBI Gene 8789] {aka CORLK}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}, SLC5A1 (solute carrier family 5 member 1) [NCBI Gene 6523] {aka D22S675, NAGT, SGLT-1, SGLT1}, FBP1 (fructose-bisphosphatase 1) [NCBI Gene 2203] {aka FBP}, NOTCH2 (notch receptor 2) [NCBI Gene 4853] {aka AGS2, HJCYS, hN2}, CHMP2B (charged multivesicular body protein 2B) [NCBI Gene 25978] {aka ALS17, CHMP2.5, DMT1, FTDALS7, VPS2-2, VPS2B}
- **Diseases:** diarrhea (MESH:D003967)
- **Chemicals:** CoCl2 (MESH:C018021), luminal (MESH:D010634)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12897086/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12897086/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12897086/full.md

---
Source: https://tomesphere.com/paper/PMC12897086